|
FAM20B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.99200722162641E-16 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.62819765950439E-11 |
| Normal-vs-Stage3 |
6.92900000043295E-07 |
| Normal-vs-Stage4 |
1.815590E-03 |
| Stage1-vs-Stage2 |
8.055800E-01 |
| Stage1-vs-Stage3 |
3.952200E-02 |
| Stage1-vs-Stage4 |
4.868000E-01 |
| Stage2-vs-Stage3 |
2.097400E-01 |
| Stage2-vs-Stage4 |
6.576800E-01 |
| Stage3-vs-Stage4 |
6.200800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62492241884138E-12 |
| Normal-vs-AfricanAmerican |
6.99440505513849E-15 |
| Normal-vs-Asian |
1.40229999834318E-08 |
| Caucasian-vs-AfricanAmerican |
8.473200E-01 |
| Caucasian-vs-Asian |
1.612060E-02 |
| AfricanAmerican-vs-Asian |
2.882000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
3.31199999648035E-08 |
| Male-vs-Female |
5.86790000000059E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.65530034124117E-10 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
1.93522975422411E-12 |
| Normal-vs-Extreme_Obese |
5.6318000263289E-09 |
| Normal_Weight-vs-Extreme_Weight |
1.029040E-01 |
| Normal_Weight-vs-Obese |
9.424800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.700200E-01 |
| Extreme_Weight-vs-Obese |
4.763600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.091400E-01 |
| Obese-vs-Extreme_Obese |
2.875600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.160130E-04 |
| Normal-vs-Age(41-60Yrs) |
9.43689570931383E-15 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
9.9298347322474E-13 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.420800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.614210E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.969500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.172100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.820100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.378100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
2.33146835171283E-15 |
| Normal-VS-KIRP CIMP |
3.209900E-02 |
| Normal-VS-Unclassified PRCC |
1.54659618445407E-11 |
| Type1 PRCC-VS-Type2 PRCC |
6.614800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.811640E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.963600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.552200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.467800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.000620E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
5.663000E-03 |
| Normal-vs-N2 |
1.449520E-02 |
| N0-vs-N1 |
4.738100E-03 |
| N0-vs-N2 |
1.693890E-02 |
| N1-vs-N2 |
9.693200E-01 |
|
|
